ZYLOX-TONBRDG.MED.TECH.H1 Financial Flexibility Index
ZYLOX-TONBRDG.MED.TECH.H1 financial flexibility index. ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Financial Flexibility Index of 1.04x as of December 2024. Free cash flow of €365.42 Million (operating CF €174.08 Million minus capex €191.34 Million) represents 1% of total liabilities (€351.56 Million). See ZYLOX-TONBRDG.MED.TECH.H1 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ZYLOX-TONBRDG.MED.TECH.H1 (2021–2024)
Financial flexibility index of ZYLOX-TONBRDG.MED.TECH.H1 from 2021 to 2024. Historical Financial Flexibility Index trend for ZYLOX-TONBRDG.MED.TECH.H1 across 4 annual periods. Check earnings quality score of ZYLOX-TONBRDG.MED.TECH.H1 to evaluate the quality of earnings relative to operating cash generation.
ZYLOX-TONBRDG.MED.TECH.H1 Financial Flexibility Index by Year (2021–2024)
ZYLOX-TONBRDG.MED.TECH.H1 financial flexibility index by year from 2021 to 2024. Year-by-year free cash flow to debt coverage for ZYLOX-TONBRDG.MED.TECH.H1. For the full cash flow conversion analysis, see ZYLOX-TONBRDG.MED.TECH.H1 cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.04x | €365.42 Million | €174.08 Million | €351.56 Million | ▲ +17.9% |
| 2023 | 0.88x | €289.36 Million | €98.44 Million | €328.32 Million | ▲ +160.6% |
| 2022 | 0.34x | €53.96 Million | €-91.32 Million | €159.54 Million | ▲ +231.7% |
| 2021 | -0.26x | €-26.61 Million | €-116.21 Million | €103.61 Million | — |